Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.
Détails
ID Serval
serval:BIB_82AC98A4A128
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.
Périodique
Journal of Neurology
Collaborateur⸱rice⸱s
Multiple Sclerosis Therapy Consensus Group (MSTCG)
Contributeur⸱rice⸱s
Baumhackl U., Berger T., Deisenhammer F., Fazekas F., Freimüller M., Kollegger H., Kristoferitsch W., Lassmann H., Markut H., Strasser-Fuchs S., Vass K., Sindic C., D'hooghe MB., Podobnik S., Havrdova E., Elovaara I., Clanet M., Confavreux C., Edan G., Lubetzki C., Altenkirch H., Bamborschke S., Baum K., Bayas A., Benecke R., Brück W., Buttmann M., Chan A., Daumer M., Dommasch D., Elias WG., Fasshauer E., Flachenecker P., Gold R., Haas J., Haferkamp G., Haller P., Hartung HP., Heesen C., Heibel M., Heidenreich F., Hemmer B., Henze T., Hohlfeld R., Janzen RW., Japp G., Jung S., Jügelt E., Kallmann B., Kieseier BC., Kleinschnitz C., Köhler J., Köhler W., Kölmel W., König N., Lehrieder G., Leussink V., Lowitzsch K., Mäurer M., Manegold U., Melms A., Mertin J., Meuth SG., Neuhaus O., Oschmann P., Petereit HF., Pette M., Pöhlau D., Pohl D., Rieckmann P., Ruprecht K., Sailer M., Schipper H., Schmidt S., Schock G., Schulz M., Schwarz S., Schwendemann G., Seidel D., Sommer N., Stangel M., Stark E., Steinbrecher A., Stoll G., Toyka KV., Tumani H., Voltz R., Weber F., Weilbach F., Wiendl H., Wiethölter H., Wildemann B., Zettl UK., Ziemssen T., Zipp F., Zschenderlein R., Orologas A., Guseo A., Bergmann S., Pugliatti M., Myhr KM., Izquierdo G., Bassetti C., Beer K., Beer S., Buettner U., Chofflon M., Gass A., Goebels N., Götschi-Fuchs M., Kappos L., Kesselring K., Ludin HP., Mattle H., Schluep M., Vaney C., Bates D.
ISSN
0340-5354 (Print)
ISSN-L
0340-5354
Statut éditorial
Publié
Date de publication
2008
Volume
255
Numéro
10
Pages
1449-1463
Langue
anglais
Notes
Publication types: Consensus Development Conference ; Journal Article ; Practice GuidelinePublication Status: ppublish. M. Schluep fait partie de Multiple Sclerosis Therapy Consensus Group (MSTCG).
Résumé
This review updates and extends earlier Consensus Reports related to current basic and escalating immunomodulatory treatments in multiple sclerosis (MS). The recent literature has been extracted for new evidence from randomized controlled trials, open treatment studies and reported expert opinion, both in original articles and reviews, and evaluates indications and safety issues based on published data. After data extraction from published full length publications and critically weighing the evidence and potential impact of the data, the review has been drafted and circulated within the National MS Societies and the European MS Platform to reach consensus within a very large group of European experts, combining evidence-based criteria and expert opinion where evidence is still incomplete. The review also outlines a few areas of controversy and delineates the need for future research.
Mots-clé
Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal/pharmacology, Antibodies, Monoclonal, Humanized, Azathioprine/pharmacology, Azathioprine/therapeutic use, Europe, Health Planning Guidelines, Humans, Immunoglobulins, Intravenous/pharmacology, Immunoglobulins, Intravenous/therapeutic use, Immunologic Factors/administration & dosage, Immunologic Factors/therapeutic use, Interferon-beta/pharmacology, Interferon-beta/therapeutic use, Magnetic Resonance Imaging, Mitoxantrone/pharmacology, Mitoxantrone/therapeutic use, Multiple Sclerosis/diagnosis, Multiple Sclerosis/therapy, Peptides/pharmacology, Peptides/therapeutic use, Plasmapheresis, Randomized Controlled Trials as Topic, Societies/standards
Pubmed
Web of science
Création de la notice
10/02/2010 11:26
Dernière modification de la notice
20/08/2019 15:42
Données d'usage
